HB 2427
An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for definitions and providing for utilization management for stage four, advanced metastatic cancer drugs; and making a repeal.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill amends Pennsylvania’s Insurance Company Law to address quality healthcare accountability, specifically regarding treatment for stage four, advanced metastatic cancer. It introduces a new definition for this cancer stage and establishes utilization management rules for drugs used to treat it. The bill also repeals a previous law, the Fair Access to Cancer Treatment Law, with provisions to ensure continuity of existing programs and agreements.
Key provisions
- Defines ‘Stage four, advanced metastatic cancer’ as cancer that has spread to other parts of the body.
- Requires insurers to allow coverage for approved drugs for stage four cancer without requiring prior failure with other drugs.
- Establishes that drug prescriptions must align with best clinical practices and be supported by medical literature.
- Repeals the Fair Access to Cancer Treatment Law of 2020.
- Provides for the continuation of existing programs and agreements initiated under the repealed law.
- Specifies that differences in language between the amended law and the repealed law are for stylistic consistency only.
- Sets an effective date of immediately upon enactment.
Who is affected
- Health insurance policyholders
- Cancer patients undergoing stage four treatment
- Insurance companies
- Healthcare providers
- Pharmaceutical companies
Notable changes
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Benjamin Sanchez
David Delloso
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours